196 results on '"De Bernardis, Flavia"'
Search Results
2. Comparison of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis adhesive properties and pathogenicity
3. Bicyclic peptidomimetics targeting secreted aspartic protease 2 (SAP2) from Candida albicans reveal a constrained inhibitory chemotype
4. Human Domain Antibodies against Virulence Traits of Candida albicans Inhibit Fungus Adherence to Vaginal Epithelium and Protect against Experimental Vaginal Candidiasis
5. Antiretroviral Therapy with Protease Inhibitors Has an Early, Immune Reconstitution-Independent Beneficial Effect on Candida Virulence and Oral Candidiasis in Human Immunodeficiency Virus-Infected Subjects
6. In vitro and in vivo Anticandidal Activity of Human Immunodeficiency Virus Protease Inhibitors
7. Evidence That Members of the Secretory Aspartyl Proteinase Gene Family, in Particular SAP2, Are Virulence Factors for Candida Vaginitis
8. Evaluation of efficacy, pharmacokinetics and tolerability of peptidomimetic aspartic proteinase inhibitors as cream formulation in experimental vaginal candidiasis
9. Use of 65-kDa mannoprotein gene primers for real-time identification of Candida albicans
10. Animal Models of Mucosal Candida Infections
11. Use of 65 kDa mannoprotein gene primers in Real Time PCR identification of Candida albicans in biological samples
12. Role of CpALS4790 and CpALS0660 in Candida parapsilosis Virulence: Evidence from a Murine Model of Vaginal Candidiasis
13. CpALS4770 and CpALS4780 contribution to the virulence of Candida parapsilosis
14. Ultrastructural localization of the secretory aspartyl proteinase in Candida albicans cell wall in vitro and in experimentally infected rat vagina
15. Lack of circulating Candida mannoprotein antigen in patients with focal hepatosplenic candidiasis
16. In vitro and in vivo activity of tea tree oil against azole-susceptible and -resistant human pathogenic yeasts
17. Role of protease inhibitors in preventing recurrent oral candidosis in patients with HIV infection: a prospective case-control study
18. The MP65 gene is required for cell wall integrity, adherence to epithelial cells and biofilm formation in Candida albicans
19. New immunotherapeutic strategies to control vaginal candidiasis
20. In vivo activity of terpinen-4-ol, the main bioactive component of Melaleuca alternifolia Cheel (tea tree) oil against azole-susceptible and -resistant human pathogenic Candida species
21. Candida vaginitis: virulence, host response and vaccine prospects
22. Evidence for a Role for Secreted Aspartate Proteinase of Candida albicans in Vulvovaginal Candidiasis
23. AIDS-related mycoses: the way forward
24. Use of SCW4 gene primers in PCR methods for the identification of six medically important Aspergillus species
25. Potential therapeutic effect of yeast killer toxin
26. Studies of Immune Responses in Candida vaginitis
27. Candida albicans OPI1 Regulates Filamentous Growth and Virulence in Vaginal Infections, but Not Inositol Biosynthesis
28. Studies on the isolation, growth and maintenance of Malassezia pachydermatis
29. IL-22 and IDO1 Affect Immunity and Tolerance to Murine and Human Vaginal Candidiasis
30. A virosomal vaccine against candidal vaginitis: Immunogenicity, efficacy and safety profile in animal models
31. Peptides of the Constant Region of Antibodies Display Fungicidal Activity
32. A highly immunogenic recombinant and truncated protein of the secreted aspartic proteases family (rSap2t) ofCandida albicansas a mucosal anticandidal vaccine
33. Loss of Mitochondrial Functions Associated with Azole Resistance in Candida glabrata Results in Enhanced Virulence in Mice
34. Rapid, simple, and low-cost identification of Candida species using high-resolution melting analysis
35. Plant production of anti-β-glucan antibodies for immunotherapy of fungal infections in humans
36. The MP65 gene is required for cell wall integrity, adherence to epithelial cells and biofilm formation in Candida albicans
37. Outcome of experimental rat vaginitis by Candida albicans isolates with different karyotypes
38. Protection against rat vaginal candidiasis by adoptive transfer of vaginal B lymphocytes
39. Identification of Inhibitors of Drug-Resistant Candida albicans Strains from a Library of Bicyclic Peptidomimetic Compounds
40. Molecular biotyping in experimental and clinical studies
41. Protection by Anti-β-Glucan Antibodies Is Associated with Restricted β-1,3 Glucan Binding Specificity and Inhibition of Fungal Growth and Adherence
42. Transcriptional profiling of theCandida albicansSsk1p receiver domain point mutants and their virulence
43. Increase of Virulence and Its Phenotypic Traits in Drug-Resistant Strains of Candida albicans
44. Anticandidal Immunity and Vaginitis: Novel Opportunities for Immune Intervention
45. The 65�kDa mannoprotein gene of Candida albicans encodes a putative ?-glucanase adhesin required for hyphal morphogenesis and experimental pathogenicity
46. Human Domain Antibodies against Virulence Traits ofCandida albicansInhibit Fungus Adherence to Vaginal Epithelium and Protect against Experimental Vaginal Candidiasis
47. In vivo activity of terpinen-4-ol, the main bioactive component of Melaleuca alternifolia Cheel (tea tree) oil against azole-susceptible and -resistant human pathogenic Candida species
48. Use of 65kDa mannoprotein gene primers in Real Time PCR identification of Candida albicans in biological samples
49. Azole Resistance of Candida glabrata in a Case of Recurrent Fungemia
50. Phenotypic and Functional Characterization of Vaginal Dendritic Cells in a Rat Model ofCandida albicansVaginitis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.